Acorda Therapeutics, Inc. is a pharmaceutical company based in Newport Beach, CA, specializing in the development and production of innovative treatments for neurological disorders. Their flagship product, INBRIJA, is an on-demand therapy designed to alleviate OFF episodes in patients with Parkinson's disease who are undergoing carbidopa levodopa treatment. With a focus on efficacy and safety, Acorda Therapeutics aims to improve the quality of life for individuals living with Parkinson's disease.
As a leader in the field, Acorda Therapeutics provides comprehensive support and resources for healthcare professionals, including prescribing options, prescribing information, and access to patient and care partner websites. Their commitment to patient care is evident through their nurse educator support, prescription support services, and savings programs. With INBRIJA being covered by most commercial plans, Acorda Therapeutics strives to ensure accessibility and affordability for patients in need of their innovative treatment.
Generated from the website
